These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 38948250)

  • 21. Investigating subtypes of lung adenocarcinoma by oxidative stress and immunotherapy related genes.
    Duan G; Huang C; Zhao J; Zhang Y; Zhao W; Dai H
    Sci Rep; 2023 Nov; 13(1):20930. PubMed ID: 38017020
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of Immune Subtypes of Esophageal Adenocarcinoma to Predict Prognosis and Immunotherapy Response.
    Ling C; Zhou X; Gao Y; Sui X
    Pharmaceuticals (Basel); 2022 May; 15(5):. PubMed ID: 35631431
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pyroptosis, apoptosis, and necroptosis molecular subtype derived prognostic signature universal applicable for gastric cancer-A large sample and multicenter retrospective analysis.
    Huo J; Xie W; Fan X; Sun P
    Comput Biol Med; 2022 Oct; 149():106037. PubMed ID: 36044785
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gene set enrichment analysis identifies immune subtypes of kidney renal clear cell carcinoma with significantly different molecular and clinical properties.
    Chen Z; Cao W; Luo J; Abdelrahman Z; Lu Q; Wang H; Wang X
    Front Immunol; 2023; 14():1191365. PubMed ID: 37426638
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ITGB1 as a prognostic biomarker correlated with immune suppression in gastric cancer.
    Gu W; Sun H; Zhang M; Mo S; Tan C; Ni S; Yang Z; Wang Y; Sheng W; Wang L
    Cancer Med; 2023 Jan; 12(2):1520-1531. PubMed ID: 35864742
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolic pathway-based molecular subtyping of colon cancer reveals clinical immunotherapy potential and prognosis.
    Dai Z; Peng X; Guo Y; Shen X; Ding W; Fu J; Liang Z; Song J
    J Cancer Res Clin Oncol; 2023 Jun; 149(6):2393-2416. PubMed ID: 35731273
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A 9‑gene expression signature to predict stage development in resectable stomach adenocarcinoma.
    Liu Z; Liu H; Wang Y; Li Z
    BMC Gastroenterol; 2022 Oct; 22(1):435. PubMed ID: 36241983
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reproduction of the Cancer Genome Atlas (TCGA) and Asian Cancer Research Group (ACRG) Gastric Cancer Molecular Classifications and Their Association with Clinicopathological Characteristics and Overall Survival in Moroccan Patients.
    Nshizirungu JP; Bennis S; Mellouki I; Sekal M; Benajah DA; Lahmidani N; El Bouhaddouti H; Ibn Majdoub K; Ibrahimi SA; Celeiro SP; Viana-Pereira M; Munari FF; Ribeiro GG; Duval V; Santana I; Reis RM
    Dis Markers; 2021; 2021():9980410. PubMed ID: 34367379
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Establishment of the molecular subtypes and a risk model for stomach adenocarcinoma based on genes related to reactive oxygen species.
    Li G; Ping M; Zhang W; Wang Y; Zhang Z; Su Z
    Heliyon; 2024 Mar; 10(5):e27079. PubMed ID: 38463816
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Spatial Metabolomics Identifies Distinct Tumor-Specific Subtypes in Gastric Cancer Patients.
    Wang J; Kunzke T; Prade VM; Shen J; Buck A; Feuchtinger A; Haffner I; Luber B; Liu DHW; Langer R; Lordick F; Sun N; Walch A
    Clin Cancer Res; 2022 Jul; 28(13):2865-2877. PubMed ID: 35395077
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular Subtyping of Triple-Negative Breast Cancers by Immunohistochemistry: Molecular Basis and Clinical Relevance.
    Zhao S; Ma D; Xiao Y; Li XM; Ma JL; Zhang H; Xu XL; Lv H; Jiang WH; Yang WT; Jiang YZ; Zhang QY; Shao ZM
    Oncologist; 2020 Oct; 25(10):e1481-e1491. PubMed ID: 32406563
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comprehensive Analysis of the Aberrance and Functional Significance of Ferroptosis in Gastric Cancer.
    Xiao J; Zheng L; Liu J
    Front Pharmacol; 2022; 13():919490. PubMed ID: 35903347
    [No Abstract]   [Full Text] [Related]  

  • 33. Phenotypic subtypes predict outcomes in colorectal cancer.
    Kasurinen J; Beilmann-Lehtonen I; Kaprio T; Hagström J; Haglund C; Böckelman C
    Acta Oncol; 2023 Mar; 62(3):245-252. PubMed ID: 36867078
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A molecular classification of gastric cancer associated with distinct clinical outcomes and validated by an XGBoost-based prediction model.
    Li B; Zhang F; Niu Q; Liu J; Yu Y; Wang P; Zhang S; Zhang H; Wang Z
    Mol Ther Nucleic Acids; 2023 Mar; 31():224-240. PubMed ID: 36700042
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical Outcome From Oxaliplatin Treatment in Stage II/III Colon Cancer According to Intrinsic Subtypes: Secondary Analysis of NSABP C-07/NRG Oncology Randomized Clinical Trial.
    Song N; Pogue-Geile KL; Gavin PG; Yothers G; Kim SR; Johnson NL; Lipchik C; Allegra CJ; Petrelli NJ; O'Connell MJ; Wolmark N; Paik S
    JAMA Oncol; 2016 Sep; 2(9):1162-9. PubMed ID: 27270348
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Collagen-related gene expression level predicts the prognosis and immune therapy response.
    Wang J; Liu Z; Lin L; Wu Z; Gao X; Cai X; Chang L; Xia X; Zhang H; Chen G
    Gastric Cancer; 2023 Nov; 26(6):891-903. PubMed ID: 37543986
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant Chemotherapy.
    Seiler R; Ashab HAD; Erho N; van Rhijn BWG; Winters B; Douglas J; Van Kessel KE; Fransen van de Putte EE; Sommerlad M; Wang NQ; Choeurng V; Gibb EA; Palmer-Aronsten B; Lam LL; Buerki C; Davicioni E; Sjödahl G; Kardos J; Hoadley KA; Lerner SP; McConkey DJ; Choi W; Kim WY; Kiss B; Thalmann GN; Todenhöfer T; Crabb SJ; North S; Zwarthoff EC; Boormans JL; Wright J; Dall'Era M; van der Heijden MS; Black PC
    Eur Urol; 2017 Oct; 72(4):544-554. PubMed ID: 28390739
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New insights for precision treatment of glioblastoma from analysis of single-cell lncRNA expression.
    Meng Q; Zhang Y; Li G; Li Y; Xie H; Chen X
    J Cancer Res Clin Oncol; 2021 Jul; 147(7):1881-1895. PubMed ID: 33693962
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Heterogeneity of MSI-H gastric cancer identifies a subtype with worse survival.
    Yang Y; Shi Z; Bai R; Hu W
    J Med Genet; 2021 Jan; 58(1):12-19. PubMed ID: 32170001
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comprehensive analysis of the immunogenic cell death-related signature for predicting prognosis and immunotherapy efficiency in patients with lung adenocarcinoma.
    Cui Y; Li Y; Long S; Xu Y; Liu X; Sun Z; Sun Y; Hu J; Li X
    BMC Med Genomics; 2023 Aug; 16(1):184. PubMed ID: 37553698
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.